Electrolytes in Chronic Kidney Disease Patients With Acute Coronary Syndrome
NCT ID: NCT05134220
Last Updated: 2021-11-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2021-11-30
2022-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. find the relation between electrolytes disturbance and renal diseases
2. the effect of electrolyte abnormalities on atherosclerosis
3. prevalence of acute coronary syndrome in patients with chronic kidney disease
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronic Kidney Disease (CKD) patients with acute coronary syndrome
The CKD patients with or without dialysis who admitted to coronary care unit with chest pain consistent with ACS with any of following features :
1. Electrocardiogram (ECG) changes:
* ST elevation.
* ST depression.
* T wave inversion.
* recent left bundle branch block.
2. Troponin elevation.
Serum Calcium
* Serum calcium level.
* Serum phosphorus level. will be measured to all study population
Chronic Kidney Disease (CKD) patients without acute coronary syndrome
The CKD patient with or without dialysis with no previous history of ACS.
Serum Calcium
* Serum calcium level.
* Serum phosphorus level. will be measured to all study population
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Serum Calcium
* Serum calcium level.
* Serum phosphorus level. will be measured to all study population
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
a- Electrocardiogram (ECG) changes:
* ST elevation.
* ST depression.
* T wave inversion.
* recent left bundle branch block.
b- Troponin T elevation.
2-The CKD patient with or without dialysis with no previous history of ACS.
Exclusion Criteria
2. Acute Kidney injury (AKI) which is defined as any of the following:(KDIGO2012)
* Increase in S.Cr by ≥ 0.3 mg/dl (≥ 26.5 μmol/l) within 48hours; or
* Increase in S.Cr to ≥ 1.5 times baseline, which is known or presumed to have occurred within the prior 7 days;or
* Urine volume \<0.5 ml/kg/h for 6 hours
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Mohamed Youssif
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sohag university
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hassan A Elnoaman, Professor
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998 Apr;31(4):607-17. doi: 10.1053/ajkd.1998.v31.pm9531176.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Electrolytes
Identifier Type: -
Identifier Source: org_study_id